Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis
Open Access
- 1 November 2010
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 130 (11) , 2583-2593
- https://doi.org/10.1038/jid.2010.200
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- A four‐gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosisArthritis & Rheumatism, 2010
- A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunityProceedings of the National Academy of Sciences, 2008
- Toll-like receptors, wound healing, and carcinogenesisJournal of Molecular Medicine, 2008
- Molecular Subsets in the Gene Expression Signatures of Scleroderma SkinPLOS ONE, 2008
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008
- Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patientsAnnals of the Rheumatic Diseases, 2007
- Infectious disease, the innate immune response, and fibrosisJournal of Clinical Investigation, 2007
- Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13Proceedings of the National Academy of Sciences, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006
- In Psoriasis Lesional Skin the Type I Interferon Signaling Pathway Is Activated, Whereas Interferon-α Sensitivity Is UnalteredJournal of Investigative Dermatology, 2004